Thus, we suggest that excessive activation of IL-23p19-mediated pro-inflammatory pathways due to NOD2 over-expression may be responsible for the occurrence of intestinal inflammation in IBD patients. This evidence concerns the gene NOD2 and inflammatory bowel disease.